跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NORGESIC paracetamol orphenadrine citrate tablet jar - TGA Drug Approval Details
Approvals
/
TGA
/
NORGESIC paracetamol orphenadrine citrate tablet jar
Approved
STANDARD
NORGESIC paracetamol orphenadrine citrate tablet jar
iNova Pharmaceuticals (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
97a2a6baf481bcac
Company
iNova Pharmaceuticals (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
97a2a6baf481bcac
Product Name
NORGESIC paracetamol orphenadrine citrate tablet jar
Artg Id
10574
Artg Name
NORGESIC paracetamol orphenadrine citrate tablet jar
Sponsor
iNova Pharmaceuticals (Australia) Pty Ltd
Company Detail Path
/organization/inova-pharmaceuticals-australia-pty-limited
Artg Date
1991-07-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/a38153e7d1f90b58def4f7e8b3f8fe61.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
97a2a6baf481bcac
Type
Standard
Back to TGA Approvals
